Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Carpenter

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The Annals of Thoracic Surgery|April 17, 2016
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction TherapyPamela Samson, Varun Puri, Clifford Robinson, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 21, 2021
PPAR<b>α</b> agonist fenofibrate attenuates iron-induced liver injury in mice by modulating the Sirt3 and <b>β</b>-catenin signalingAshok Mandala, William J Chen, Austin Armstrong, et al.
Muscle & Nerve|August 1, 2009
A RYR1 mutation associated with recessive congenital myopathy and dominant malignant hyperthermia in Asian familiesDanielle Carpenter, Azzam Ismail, Rachel L Robinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levelsMark Booth, Marie A Shaw, Danielle Carpenter, et al.
Virchows Archiv : an International Journal of Pathology|April 10, 2025
Clinical associations of portal-based disease in MASLD: proposal of a new histological scoring systemDaniela S Allende, Cynthia D Guy, David E Kleiner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 12, 2024
Fibrosis, biomarkers and liver biopsy in AAT deficiency and relation to liver Z protein polymer accumulationAnandini Suri, Zidong Zhang, Brent Neuschwander-Tetri, et al.
Molecular Metabolism|November 10, 2021
Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitisSandip Mukherjee, Molee Chakraborty, Barbara Ulmasov, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2020
Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosisDaniela S Allende, Samer Gawrieh, Oscar W Cummings, et al.
Molecular Metabolism|July 10, 2023
Ube4A maintains metabolic homeostasis and facilitates insulin signaling in vivoSandip Mukherjee, Molee Chakraborty, Eliwaza N Msengi, et al.
Pediatric Transplantation|October 11, 2021
Novel NMP split liver model recapitulates human IRI and demonstrates ferroptosis modulators as a new therapeutic strategyMustafa Nazzal, Erik C Madsen, Austin Armstrong, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The Annals of Thoracic Surgery|April 17, 2016
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction TherapyPamela Samson, Varun Puri, Clifford Robinson, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 21, 2021
PPAR<b>α</b> agonist fenofibrate attenuates iron-induced liver injury in mice by modulating the Sirt3 and <b>β</b>-catenin signalingAshok Mandala, William J Chen, Austin Armstrong, et al.
Muscle & Nerve|August 1, 2009
A RYR1 mutation associated with recessive congenital myopathy and dominant malignant hyperthermia in Asian familiesDanielle Carpenter, Azzam Ismail, Rachel L Robinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levelsMark Booth, Marie A Shaw, Danielle Carpenter, et al.
Virchows Archiv : an International Journal of Pathology|April 10, 2025
Clinical associations of portal-based disease in MASLD: proposal of a new histological scoring systemDaniela S Allende, Cynthia D Guy, David E Kleiner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 12, 2024
Fibrosis, biomarkers and liver biopsy in AAT deficiency and relation to liver Z protein polymer accumulationAnandini Suri, Zidong Zhang, Brent Neuschwander-Tetri, et al.
Molecular Metabolism|November 10, 2021
Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitisSandip Mukherjee, Molee Chakraborty, Barbara Ulmasov, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2020
Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosisDaniela S Allende, Samer Gawrieh, Oscar W Cummings, et al.
Molecular Metabolism|July 10, 2023
Ube4A maintains metabolic homeostasis and facilitates insulin signaling in vivoSandip Mukherjee, Molee Chakraborty, Eliwaza N Msengi, et al.
Pediatric Transplantation|October 11, 2021
Novel NMP split liver model recapitulates human IRI and demonstrates ferroptosis modulators as a new therapeutic strategyMustafa Nazzal, Erik C Madsen, Austin Armstrong, et al.
Pageof 4